A study of Trichostatin-A for hematologic malignancies
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Trichostatin A (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 14 Feb 2018 According to a Vanda Pharmaceuticals media release, trial is expected to start in the second half of 2018.
- 17 Feb 2017 New trial record
- 15 Feb 2017 According to a Vanda Pharmaceuticals media release, the company expects to submit an investigational new drug application to the FDA in mid 2017 for trichostatin A.